DASH trial - Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage |
|
Amendments« Back to main documents page |
|
SA/01/19 and SA/02/19
PI change for C007: Royal Devon and Exeter Hospital (Wonford)
and approval of day 90 follow-up postal form.
|
|
SA/03/19
Covers changes to approved protocol, information sheets, consent forms
and GP letter.
|
|
MA/04/19
Covers changes consent forms and information sheets.
|
|
MA/05/20
Recruitment extended to 30 June 2020,
follow-up extended to 30 September 2020.
|
|
MA/06/20
Recruitment extended to 31 December 2020,
follow-up extended to 31 March 2021.
|
|
MA/07/21
Recruitment extended to 31 September 2021,
follow-up extended to 30 December 2021.
|
|
SA/04/21 |
|
MA/08/21
Site C005: Derby, closed to recruitment on 30 September 2021.
|
|
MA/09/21
Recruitment extended to 31 March 2022,
follow-up extended to 30 June 2022.
|
|
MA/10/22
Added Edoxaban and Lixiana to day 90 follow-up CRF.
|
|
MA/11/22
Site C009: Aberdeen Royal Infirmary, closed to recruitment after using
their last IMP treatment pack on 29 December 2021.
|
|
MA/12/22
The approved protocol has been updated to include additional blood sample
analyses that will be performed in Oxford.
|